Secobarbital

Chemical formula: C₁₂H₁₈N₂O₃  Molecular mass: 238.283 g/mol  PubChem compound: 5193

Active ingredient description

Secobarbital is a barbituric acid derivative. Secobarbital binds at a distinct binding site associated with a Cl ionopore at the GABAA receptor, increasing the duration of time for which the Cl ionopore is open.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
N05CA06 Secobarbital N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CA Barbiturates, plain
Discover more medicines within N05CA06

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
SECONAL Capsule FDA, National Drug Code (US) MPI, US: SPL/Old

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 76-73-3
DrugBank Drug: DB00418
KEGG Drug: D00430
PubChem Compound: 5193
RxNorm Ingredient: 9624
SNOMED-CT Concept: 372737001
Secobarbital (substance)
UNII Identifier: 1P7H87IN75
SECOBARBITAL

Medicines

Secobarbital is an active ingredient of these brands:

United States (US)

Japan (JP)

  • IONAL as SECOBARBITAL SODIUM

United Kingdom (UK)

  • SECONAL as SECOBARBITAL SODIUM

  • (combination) TUINAL as SECOBARBITAL SODIUM

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.